Diabetes Self-Management Blog

On December 8, the US Food and Drug Administration (FDA) approved a novel tool for diabetes management known as the V-Go Disposable Insulin Delivery Device.

The V-Go, which is intended to replace multiple daily insulin injections, adheres to the skin and is designed to be worn under the clothing for 24 hours before being replaced. It delivers basal and bolus insulin subcutaneously (under the skin) through a microneedle; the device can deliver preset basal rates of 20, 30, or 40 units of insulin in a 24-hour period (0.83 units/hour, 1.25 units/hour, or 1.67 units/hour, respectively) and on-demand bolus doses in 2-unit increments up to a total of 36 units in a 24-hour period. The V-Go, which is approved for use in adults with Type 2 diabetes, uses no electronic parts and weighs roughly 1 ounce when full.

Kristine Paterson, CEO of manufacturer Valeritas, Inc., says, “The V-Go Disposable Insulin Delivery Device is the first fully disposable, nonelectronic basal-bolus device that is specifically designed with the Type 2 population in mind. We believe that the simple user features of the V-Go will allow more patients with diabetes to adhere to their insulin regimen, which ultimately may lead to better control.”

V-Go is scheduled to become commercially available in the United States in 2011. Pricing details have not yet been disclosed.

For more information about the V-Go Disposable Insulin Delivery Device, see the press release from Valeritas. And for a visual demonstration of how the device works, click here.

POST A COMMENT       
  

We are currently experiencing technical difficulties with our commenting system. Thank you for your patience as we work to resolve them.


Tools & Technology
FDA Approves Remote Glucose-Monitoring Technology (10/24/14)
Information at Our Fingertips (09/04/14)
Support Medicare Coverage of CGMs (09/02/14)
Children With Diabetes "Focus on Technology" Conference (07/28/14)

Diane Fennell
A Gram of Turmeric a Day to Keep Dementia At Bay? (11/20/14)
Some Sulfonylureas May Be Safer Than Others (11/14/14)
Mediterranean Diet May Benefit Kidneys (11/06/14)
New Metformin Combination Medicine Approved for Type 2 Diabetes (10/30/14)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.